Menu Search
Equities

Nutriband Inc

NTRB:NAQ

Nutriband Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)5.33
  • Today's Change-0.23 / -4.14%
  • Shares traded15.56k
  • 1 Year change+139.01%
  • Beta0.3966
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Nutriband Inc was unable to grow net income despite reducing the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percent of sales). Net income shrank 22.35% from a loss of 4.48m to a larger loss of 5.49m despite revenues that were flat.
Gross margin33.62%
Net profit margin-401.62%
Operating margin-402.01%
Return on assets-61.64%
Return on equity-74.87%
Return on investment-67.30%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Nutriband Inc fell by 1.49m. Cash Flow from Financing totalled 2.09m or 100.07% of revenues. In addition the company used 3.53m for operations while cash used for investing totalled 51.76k.
Cash flow per share-0.7663
Price/Cash flow per share--
Book value per share1.12
Tangible book value per share0.6154
More ▼

Balance sheet in USDView more

Nutriband Inc uses little debt in its capital structure as supported by a debt to capital ratio of 1.56%.
Current ratio6.57
Quick ratio6.36
Total debt/total equity0.0158
Total debt/total capital0.0156
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.